Tracking the hidden threat: antibodies that can sabotage Life-Saving transplants
NCT ID NCT06395220
Summary
This study aimed to understand how often harmful antibodies develop after a stem cell transplant from a partially matched donor. Researchers followed 314 patients with blood cancers to track these antibodies and identify what factors cause them to appear. The goal was to gather knowledge to help prevent transplant rejection and failure in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMATOLOGICAL MALIGNANCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
People's Hospital of Peking University
Beijing, China
Conditions
Explore the condition pages connected to this study.